Smoking causes induction of micronuclei and other nuclear anomalies in cervical cells.


Journal

International journal of hygiene and environmental health
ISSN: 1618-131X
Titre abrégé: Int J Hyg Environ Health
Pays: Germany
ID NLM: 100898843

Informations de publication

Date de publication:
05 2020
Historique:
received: 07 11 2019
revised: 03 02 2020
accepted: 13 02 2020
pubmed: 24 2 2020
medline: 9 2 2021
entrez: 24 2 2020
Statut: ppublish

Résumé

Smoking is an independent cause of cervical cancer, which is the 4th most common malignancy in women. It is currently not known if tobacco consumption causes chromosomal damage (which is a hallmark of human cancer) in cervical cells and if age and the hormonal status have an impact on tobacco induced genetic instability in the cervix. We conducted a study with pre- and post-menopausal women smokers and never-smokers (25/group). Smokers consumed 30 light/medium cigarettes/day and were matched with the non-smoking group. Cervical cells were analyzed for induction of micronuclei (MN) which are caused by structural/numerical chromosomal aberrations; additionally, other nuclear anomalies reflecting genomic instability and cytotoxicity were scored. Furthermore, the frequencies of basal cells were recorded which reflect the mitotic activity of the mucosa. MN and other abnormalities were increased in both groups of smokers. The effects were most pronounced in postmenopausal smokers (i.e. 2-fold higher) compared to premenopausal smokers. Also the number of basal cells (indicative for cell proliferation) was clearly enhanced in older women. Tar and nicotine had no detectable impact on chromosomal damage but a clear association with pack-years was observed. Smoking increased chromosomal instability, cytotoxicity and induced cell divisions in cervical mucosa cells of pre- and post-menopausal women. The effects were more pronounced in the latter group indicating a higher risk for diseases (including cancer) that are causally related to DNA damage.

Identifiants

pubmed: 32088596
pii: S1438-4639(19)30999-X
doi: 10.1016/j.ijheh.2020.113492
pii:
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113492

Informations de copyright

Copyright © 2020. Published by Elsevier GmbH.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Armen Nersesyan (A)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria. Electronic address: anersesyan@yahoo.com.

Rafael Muradyan (R)

Institute of Fine Organic Chemistry, Yerevan, Armenia. Electronic address: muradyanraf@inbox.ru.

Michael Kundi (M)

Center for Public Health, Medical University of Vienna, Vienna, Austria. Electronic address: michael.kundi@meduniwien.ac.at.

Michael Fenech (M)

Genome Health Foundation, North Brighton, Australia. Electronic address: mf.ghf@outlook.com.

Claudia Bolognesi (C)

Environmental Carcinogenesis Unit, Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: claudiabolognesi@yahoo.it.

Siegfried Knasmueller (S)

Institute of Cancer Research, Medical University of Vienna, Vienna, Austria. Electronic address: siegfried.knasmueller@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH